Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (55)
  • 2024 (57)
  • 2023 (86)
  • 2022 (152)
  • 2021 (99)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4032)
  • Synthetic drugs (1075)
  • Guns/Weapons (994)
  • OCDETF/Task Force (813)
  • Fake Pills (657)
  • Arrests/Convictions - Major (607)
  • Guilty Plea (531)
  • Seizures (Drugs/Property) (460)
  • Prescription Drugs (364)
  • Overdose (322)
  • Major Law Enforcement Operation (269)
  • Take Back Day (246)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (185)
  • Fentanyl Awareness (154)
  • One Pill Can Kill (112)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Extraditions (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Fentanyl Free America (14)
  • Terrorism (14)
  • Counterfeit Pills (11)
  • Campaigns (10)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (245)
  • Task Forces/Task Force Officers (233)

Drug Name

  • Fentanyl (134)
  • Cocaine (102)
  • Heroin (74)
  • Opioids (56)
  • Methamphetamine (48)
  • Synthetic Opioids (45)
  • Oxycodone (42)
  • Marijuana (Cannabis) (15)
  • Hydromorphone (14)
  • Benzodiazepines (9)
  • Morphine (8)
  • Amphetamines (4)
  • Ecstasy/MDMA (4)
  • Marijuana Concentrates (3)
  • Methadone (3)
  • Steroids (3)
  • K2/Spice (2)
  • Ketamine (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • Xylazine (2)
  • LSD (1)

Field Division

  • Washington, DC (183)
  • New England (43)
  • New York (35)
  • New Jersey (31)
  • Seattle (24)
  • Chicago (21)
  • Houston (16)
  • Atlanta (13)
  • Miami (12)
  • El Paso (10)
  • New Orleans (10)
  • San Francisco (10)
  • Sede (10)
  • Dallas (7)
  • St. Louis (7)
  • San Diego (6)
  • Omaha (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Louisville (3)
  • Detroit (1)
Clear All Results
PRESS RELEASE

Spokane Physician Pays $120,000 to Resolve Allegations He Prescribed Controlled Substances Without Legitimate Medical Purpose

Diciembre 11, 2025
SPOKANE, Wash. –Dr. Duncan Lahtinen, a licensed physician, has paid $120,000.00 in penalties to resolve allegations that he wrote prescriptions for controlled substances that lacked legitimate medical purposes or were outside the usual course of his professional practice. Between 2017 and 2025, Dr. Lahtinen issued over 1,400 prescriptions for controlled...
Diciembre 11, 2025
PRESS RELEASE

Gang Member Sentenced to 5 Years in Federal Prison for Trafficking Narcotics in Southwestern Connecticut

Diciembre 10, 2025
BRIDGEPORT, Conn. - David X. Sullivan, United States Attorney for the District of Connecticut, announced that MODESTE ADODO, 29, was sentenced today by U.S. District Judge Michael P. Shea in Hartford to 60 months of imprisonment and three years of supervised release for trafficking narcotics. According to court documents and...
Diciembre 10, 2025
PRESS RELEASE

Hampton Roads heroin trafficker sentenced to over 23 years in prison

Diciembre 10, 2025
NORFOLK, Va. – Two Hampton Roads drug traffickers were sentenced to prison for convictions relating to their trafficking of heroin and other narcotics. “This case demonstrates the effective partnerships between our federal, state, and local law enforcement agencies,” said Lindsey Halligan, U.S. Attorney for the Eastern District of Virginia. “We...
Diciembre 10, 2025
PRESS RELEASE

DEA and Local "Trifecta" Partnership Announce 70% Reduction in Fentanyl Deaths, Proving Blueprint for 'Fentanyl Free America'

Diciembre 08, 2025
The Drug Enforcement Administration (DEA) New Orleans Division, alongside its federal, state, and local partners, today announced historic, verifiable data showing a dramatic decline in fentanyl-related overdose fatalities across the Northshore region of Louisiana. A concentrated two-year effort, known as the "Trifecta" model, has achieved unprecedented results, led by a...
Diciembre 08, 2025
PRESS RELEASE

Man Sentenced to Nine Years for Fentanyl Overdose Death

Diciembre 05, 2025
PHOENIX, Ariz. – Dominik Israel Lopez, 24, of Mesa, Arizona, was sentenced on November 24, 2025, by United States District Judge Krissa Lanham to 108 months of prison, to be followed by three years of supervised release. Lopez pleaded guilty to Distribution of Fentanyl, with death resulting. In March 2020...
Diciembre 05, 2025
PRESS RELEASE

Five Members of Hobbs Based Drug Trafficking Organization Arrested on Federal Drug Trafficking Charges

Diciembre 04, 2025
ALBUQUERQUE – Four members of the Navarrette Drug Trafficking Organization have been indicted, and one charged by a criminal complaint, on federal drug trafficking charges following an investigation into the distribution of methamphetamine, fentanyl, and cocaine in Hobbs, New Mexico. According to court documents, from October 2024, through December 2025...
Diciembre 04, 2025
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

Diciembre 04, 2025
Washington, DC – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment...
Diciembre 04, 2025
PRESS RELEASE

Former Ellensburg Doctor Indicted on 26 Felony Counts for Falsifying and Issuing Commercial Driver’s Licenses and Prescriptions for Controlled Substances

Diciembre 01, 2025
YAKIMA, Wash. – On November 14, 2025, a federal grand jury for the Eastern District of Washington returned an Indictment charging Anna Elperin, age 42, with 26 felony counts relating to prescriptions for controlled substances and Department of Transportation commercial driver’s licenses physical examinations Elperin wrote and performed at her...
Diciembre 01, 2025
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 20, 2025
SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
Noviembre 20, 2025
PRESS RELEASE

Pensacola Women Plead Guilty to Illegal Drug Diversion

Noviembre 17, 2025
PENSACOLA, FLA – Alexandra M. Christensen, 31, Lindsay N. McCray (also known as Lindsay Rogers), 42, Heather T. Bradley (also known as Heather Thomas), 37, and Jennifer E. Purves, 39, all of Pensacola, Fla., pleaded guilty in federal court to charges in connection with the unlawful diversion of controlled substances...
Noviembre 17, 2025
Showing 1 - 10 of 459 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Página 9
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster